Dowling & Yahnke LLC Fortress Biotech, Inc. Transaction History
Dowling & Yahnke LLC
- $215 Million
- Q3 2022
A detailed history of Dowling & Yahnke LLC transactions in Fortress Biotech, Inc. stock. As of the latest transaction made, Dowling & Yahnke LLC holds 20,000 shares of FBIO stock, worth $34,200. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$34,200
Previous $17,000
-0.0%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FBIO
# of Institutions
6Shares Held
1.01MCall Options Held
0Put Options Held
0-
Cpwm, LLC Seattle, WA762KShares$1.3 Million0.06% of portfolio
-
National Asset Management, Inc. Boca Raton, FL145KShares$247,4370.01% of portfolio
-
Telemetry Investments, L.L.C. New York, NY72KShares$123,1200.07% of portfolio
-
Urban Wealth Management, LLC7.64KShares$13,0550.02% of portfolio
-
American Portfolios Advisors Holbrook, NY450Shares$7690.0% of portfolio
About Fortress Biotech, Inc.
- Ticker FBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,735,000
- Market Cap $184M
- Description
- Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...